Group 1 - European stock markets declined, with the Stoxx 600 index closing down 0.5%, driven by losses in financial services, media, and tourism sectors, while personal care and utilities outperformed the market [1] - Novo Nordisk's stock plummeted after its new weight-loss injection drug underperformed compared to a competing product from Eli Lilly in a recent trial [1] - The European Parliament's major political groups announced a suspension of legislative work to approve the US-EU trade agreement following the US Supreme Court's overturning of Trump's global tariff measures, leading to new global tariffs announced by Trump [1] Group 2 - KBC Securities' global equity head noted that the current options seem limited and less impactful, which could be beneficial for consumer stocks, but concerns remain about market participants' willingness to endure upcoming volatility from tariff news [3] - Investors are already grappling with worries over high valuations and the disruptive impact of artificial intelligence, with tariff-related news adding complexity to the market landscape [3] - Significant upcoming events include Trump's State of the Union address and Nvidia's earnings report, with potential for increased volatility in software stocks following the release of Anthropic's new model [3]
欧洲股市因关税不确定性再现而下跌 诺和诺德股价重挫